Odyssey Therapeutics Inc.
ODTX | NASDAQ
$19.41
-$0.13 (-0.67%)
Nov 2, 2026, 12:39 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 |
|---|---|
Cash & Equivalents | 41.69M |
Short-Term Investments | 139.67M |
Long-Term Investments | 35.2M |
Other Long-Term Assets | 3.33M |
Receivables | n/a |
Inventory | n/a |
Other Current Assets | 9.3M |
Total Current Assets | 190.66M |
Property-Plant & Equipment | 26.01M |
Goodwill & Intangibles | 14.59M |
Total Long-Term Assets | 79.13M |
Total Assets | 269.79M |
Account Payables | 7.87M |
Deferred Revenue | n/a |
Short-Term Debt | n/a |
Other Current Liabilities | 7.14M |
Total Current Liabilities | 26.48M |
Long-Term Debt | n/a |
Other Long-Term Liabilities | 709.69M |
Total Long-Term Liabilities | 731.59M |
Total Liabilities | 758.07M |
Total Debt | 27.11M |
Book Value | -488.28M |
Book Value Per Share | -17.72 |
Common Stock | n/a |
Retained Earnings | -568.14M |
Comprehensive Income | 245K |
Shareholders Equity | -488.28M |
Total Investments | 174.87M |
Add to Watchlist
Select watchlists to add or remove ODTX